NEPH
$7.80
Nephros
NEPH
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($0.12)
Revenue:  $3.40 Mil
Wednesday
Aug 5
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, May 6, 2020

What do you expect when NEPH reports earnings?
Beat
Meet
Miss

Where is NEPH's stock price going from here?
Up
Flat
Down
Stock chart of NEPH
Analysts
Summary of analysts' recommendations for NEPH
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider.